ARTICLES
Exocrine Pancreatic Insufficiency: A Look at the FDA-Approved Pancrelipases
Exocrine pancreatic insufficiency (EPI) results when the production or delivery of pancreatic digestive enzymes is disrupted. It typically occurs as a consequence of pancreatic tissue destruction or blocked pancreatic ducts.
Carotid Revascularization: Threshold, Timing, and Best Technical Approach
Atherosclerotic internal carotid artery disease is a major contributor to ischemic stroke. Surgeons use a combination of carotid artery and brain imaging to determine if patients have symptomatic carotid stenosis. However, there remains widespread disagreement on the threshold, timing, and best technical approach to carotid revascularization in symptomatic patients.
PARP Inhibitor Lynparza Approved for BRCA-Positive Advanced Ovarian Cancer
The Food and Drug Administration approves Lynparza (olaparib) for the treatment of women with BRCA-positive advanced ovarian cancer.
Wheelchair Users: Rotator Cuff Repair
Slightly more than 6.8 million community-dwelling Americans use assistive devices (eg, canes, walkers, crutches) to help them with mobility and, of these, 1.7 million people use wheelchairs or scooter riders. These Americans at risk for unique musculoskeletal problems, especially rotator cuff injuries.
Blood Test to Screen for Coronary Heart Disease Approved by FDA
The FDA has cleared a blood test that can screen patients, especially black women, for coronary heart disease.
Chemical Compound Relieves Inflammation in Patients with Multiple Sclerosis
The chemical compound indazole chloride (Ind-Cl) initiated long lasting relief in mice models of multiple sclerosis.
FDA Approves 3-Drug Combo for the Treatment of Hepatitis C
The US Food and Drug Administration has announced the approval of a new combination treatment for hepatitis C virus.
Olaparib Approved for Advanced Ovarian Cancer
The FDA has approved the PARP inhibitor olaparib (Lynparza) for the treatment of women with BRCA-positive advanced ovarian cancer.
States Ill-Prepared for Ebola, Other Infectious Outbreaks
Half of US states are poorly prepared to prevent, detect, and respond to infectious disease outbreaks. That was the main conclusion of a report issued jointly by the Trust for America's Health and the Robert Wood Johnson Foundation.
Prostaglandin Analogue Drops Preserve Vision in Glaucoma
Prostaglandin analogue eye drops significantly reduce the risk of vision loss in patients with glaucoma, according to a new study published online Dec. 18 in The Lancet.